Proteolytic enzymes may play a role in the pathophysiology of degenerative diseases of the brain. The multicatalytic proteinase complex (MPC) first isolated and characterized in our laboratory from bovine pituitaries a decade ago, is a unique high molecular mass proteinase (700 kDa), composed of multiple non-identical subunits, and containing at least three distinct proteolytic activities. The primary structures of its cloned subunits which are highly conserved, bear no homology to any known protein but are homologous to each other. MPC is present in relatively high concentrations in brain and pituitary cytoplasm, where it likely participates in the extralysosomal degradation of ubiquitinated and non-ubiquitinated proteins. Many questions about the mechanism of its regulation and the relationship of its structure to its properties remain unanswered. We have found that chemical modification is a powerful approach to the study of structure- function relationships. Acetylation with N-acetylimidazole revealed that the initial degradation of casein may be catalyzed by a fourth component, distinct from the three components previously described and demonstrated that it is possible to prepare different catalytically active forms of the enzyme. The studies proposed in this application will employ chemical modification to characterize the individual components. N-acetylimidazole, citraconic anhydride and succinic anhydride will be used to determine the relationship of quaternary structure to function, and to prepare forms of the enzyme for characterization of the substrate specificities of each of the components. Active-site directed inhibitors will be synthesized. MPC has been isolated in both latent and activated forms. The mechanisms underlying its activation remain unknown. We have demonstrated that several MPC subunits are phosphorylated by a cAMP-dependent protein kinase that co-purifies with the proteinase. Phenyl Sepharose chromatography removes the kinase as well as the heaviest MPC subunit, while activating the degradation of casein. The possible role of phosphorylation and of the heaviest MPC subunit in the regulation of MPC activity will be explored by the application of classical and molecular biological techniques. It is likely that MPC abnormalities underlie some brain pathologies. The proposed studies should aid in our understanding of this biologically significant macromolecule.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS029936-03
Application #
2268025
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1992-07-01
Project End
1995-06-30
Budget Start
1994-07-01
Budget End
1995-06-30
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Christie, Andrew E; Stein, Wolfgang; Quinlan, John E et al. (2004) Actions of a histaminergic/peptidergic projection neuron on rhythmic motor patterns in the stomatogastric nervous system of the crab Cancer borealis. J Comp Neurol 469:153-69
Orlowski, Marian; Wilk, Sherwin (2003) Ubiquitin-independent proteolytic functions of the proteasome. Arch Biochem Biophys 415:1-5
Wilk, S; Chen, W E; Magnusson, R P (2000) Properties of the nuclear proteasome activator PA28gamma (REGgamma). Arch Biochem Biophys 383:265-71
Orlowski, M; Wilk, S (2000) Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex. Arch Biochem Biophys 383:16-Jan
Wilk, S; Chen, W E; Magnusson, R P (2000) Properties of the beta subunit of the proteasome activator PA28 (11S REG). Arch Biochem Biophys 384:174-80
Wilk, S; Chen, W E; Magnusson, R P (1999) Modulators of the activation of the proteasome by PA28 (11S reg). Mol Biol Rep 26:39-44
Wilk, S; Chen, W E; Magnusson, R P (1999) Modulation of the PA28alpha-20S proteasome interaction by a peptidyl alcohol. Arch Biochem Biophys 362:283-90
Wojcik, C; Wilk, S (1999) Changes in proteasome expression and activity during differentiation of neuronal precursor NTera 2 clone D1 cells. Neurochem Int 34:131-6
Wilk, S; Chen, W E; Magnusson, R P (1998) Properties of the proteasome activator subunit PA28 alpha and its des-tyrosyl analog. Arch Biochem Biophys 359:283-90
Wojcik, C; Tanaka, K; Paweletz, N et al. (1998) Proteasome activator (PA28) subunits, alpha, beta and gamma (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells. Eur J Cell Biol 77:151-60

Showing the most recent 10 out of 20 publications